Study checks if stopping a drug made polyps grow faster
NCT ID NCT04674228
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study reviewed medical records of 42 people with familial adenomatous polyposis (FAP) who had previously taken the drug erlotinib. Researchers wanted to see how quickly the disease progressed after the drug was stopped. The goal was to better understand what happens when treatment ends.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FAMILIAL ADENOMATOUS POLYPOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a freezing balloon zap away precancerous gut growths?
- Gut bacteria may influence polyp risk in inherited colon condition
- Could a common drug curb polyps in teens with rare genetic condition?
- Can pelvic floor exercises help pouch patients regain control?
- New drug E7386 tested for tough cancers
- Large study looks at how a 25-Gene cancer test affects patients and families